Literature DB >> 15757884

Evaluating the educational content of direct-to-consumer fulfillment materials.

Blenda A Chao1.   

Abstract

PURPOSE: The educational content of direct-to-consumer (DTC) fulfillment materials was evaluated.
METHODS: A list of prescription drug products advertised to consumers via broadcast media from August 1997 through April 20, 2002, was obtained from the Food and Drug Administration (FDA). The prescription products were categorized by disease state on the basis of their FDA-approved indications. Eight disease states were selected for analysis purposes and included acne, allergic rhinitis, depression, diabetes, hypercholesterolemia, migraine, overactive bladder, and osteoporosis. A total of 31 products were advertised directly to consumers for the eight targeted disease states, 26 of which met the inclusion criteria. The educational content of the advertisements for these 26 products was assessed by analyzing the materials' consistency, instructiveness, and consumer orientation.
RESULTS: Two of the 26 materials analyzed contained claims that potentially broadened a drug's indication from that listed in the FDA-approved labeling. The majority of materials listed the condition name (92%), symptom information (77%), the drug's mechanism of action (65%), the drug's time to onset of action (54%), and supportive behaviors (62%). Twenty of 24 DTC fulfillment materials (83%) were not written at the reading level of eighth grade or lower. Fifteen of the 26 mailings contained educational diagrams, 52% of which met the criteria for necessity, and a greater percentage met the criteria for suitability (90%), familiarity (86%), overall layout (88%), single concept (86%), and lack of distracting elements (100%).
CONCLUSION: DTC fulfillment materials appear to have more educational content than DTC print advertisements but are still overwhelmingly deficient in meeting the recommended sixth to eighth-grade reading level.

Entities:  

Mesh:

Year:  2005        PMID: 15757884     DOI: 10.1093/ajhp/62.6.620

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

Review 1.  Cancer-related direct-to-consumer advertising: a critical review.

Authors:  Emily Z Kontos; K Viswanath
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

2.  Contribution of communication inequalities to disparities in human papillomavirus vaccine awareness and knowledge.

Authors:  Emily Z Kontos; Karen M Emmons; Elaine Puleo; K Viswanath
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

3.  A Study of the Frequency and Social Determinants of Exposure to Cancer-Related Direct-to-Consumer Advertising Among Breast, Prostate, and Colorectal Cancer Patients.

Authors:  Andy S L Tan
Journal:  Health Commun       Date:  2014-10-30

4.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

5.  What are the public health effects of direct-to-consumer drug advertising?

Authors:  Elizabeth A Almasi; Randall S Stafford; Richard L Kravitz; Peter R Mansfield
Journal:  PLoS Med       Date:  2006-03-28       Impact factor: 11.069

Review 6.  Direct-to-Consumer Drug Advertisement and Prescribing Practices: Evidence Review and Practical Guidance for Clinicians.

Authors:  Miguel J Franquiz; Amy L McGuire
Journal:  J Gen Intern Med       Date:  2020-09-15       Impact factor: 5.128

7.  'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.

Authors:  Neda Khalil Zadeh; Kirsten Robertson; James A Green
Journal:  BMJ Open       Date:  2017-12-06       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.